{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:09:13Z","timestamp":1765609753827},"reference-count":123,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","bpgastro.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.bpg.2016.11.001","type":"journal-article","created":{"date-parts":[[2016,11,14]],"date-time":"2016-11-14T18:35:25Z","timestamp":1479148525000},"page":"987-999","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Surveillance in cholangiocellular carcinoma"],"prefix":"10.1016","volume":"30","author":[{"given":"Thomas C.","family":"Wirth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arndt","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2016.11.001_bib1","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","article-title":"Pathogenesis, diagnosis, and management of cholangiocarcinoma","volume":"145","author":"Rizvi","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2016.11.001_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2012.09.009","article-title":"Classification, diagnosis, and management of cholangiocarcinoma","volume":"11","author":"Razumilava","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2016.11.001_bib3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-2004-828889","article-title":"The epidemiology of cholangiocarcinoma","volume":"24","author":"Shaib","year":"2004","journal-title":"Seminars Liver Dis"},{"key":"10.1016\/j.bpg.2016.11.001_bib4","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0168-8278(02)00297-0","article-title":"Changing international trends in mortality rates for liver, biliary and pancreatic tumours","volume":"37","author":"Khan","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpg.2016.11.001_bib5","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1158\/1055-9965.EPI-05-0811","article-title":"A\u00a0comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States","volume":"15","author":"McGlynn","year":"2006","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.bpg.2016.11.001_bib6","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1053\/jhep.2001.25087","article-title":"Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States","volume":"33","author":"Patel","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2016.11.001_bib7","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3109\/00365521.2011.589472","article-title":"Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany","volume":"46","author":"von Hahn","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2016.11.001_bib8","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/hepr.12605","article-title":"Sex-specific and race\/ethnicity-specific disparities in cholangiocarcinoma incidence and prevalence in the USA: an updated analysis of the 2000\u20132011 surveillance, epidemiology and end Results registry","volume":"46","author":"Mosadeghi","year":"2016","journal-title":"Hepatol Res"},{"key":"10.1016\/j.bpg.2016.11.001_bib9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bpg.2015.02.003","article-title":"Epidemiology of cholangiocarcinoma","volume":"29","author":"Bergquist","year":"2015","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2016.11.001_bib10","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","article-title":"Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise","volume":"21","author":"Saha","year":"2016","journal-title":"The Oncologist"},{"key":"10.1016\/j.bpg.2016.11.001_bib11","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/jnci\/djk201","article-title":"Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002","volume":"99","author":"Jepsen","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.bpg.2016.11.001_bib12","article-title":"Intrahepatic cholangiocarcinoma: epidemiology, risk factors, diagnosis and surgical management","author":"Zhang","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bpg.2016.11.001_bib13","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/hep.26958","article-title":"Changing pattern of epidemiology in intrahepatic cholangiocarcinoma","volume":"60","author":"Njei","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2016.11.001_bib14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4251\/wjgo.v2.i11.407","article-title":"Intra-hepatic and extra-hepatic cholangiocarcinoma: new insight into epidemiology and risk factors","volume":"2","author":"Cardinale","year":"2010","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.bpg.2016.11.001_bib15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/MOG.0b013e3282fbf9b3","article-title":"Cholangiocarcinoma: lessons from Thailand","volume":"24","author":"Sripa","year":"2008","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.bpg.2016.11.001_bib16","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jaad.2013.11.045","article-title":"Five-year malignancy incidence in patients with chronic pruritus: a population-based cohort study aimed at limiting unnecessary screening practices","volume":"70","author":"Fett","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.bpg.2016.11.001_bib17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24351","article-title":"Risk factors for cholangiocarcinoma","volume":"54","author":"Tyson","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2016.11.001_bib18","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1572-0241.2007.01103.x","article-title":"The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis","volume":"102","author":"Kaplan","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2016.11.001_bib19","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0168-8278(94)80240-8","article-title":"Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver","volume":"21","author":"Escorsell","year":"1994","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpg.2016.11.001_bib20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/00365529850166284","article-title":"Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population","volume":"33","author":"Boberg","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2016.11.001_bib21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"Bergquist","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpg.2016.11.001_bib22","first-page":"867","article-title":"Primary sclerosing cholangitis: diagnosis and treatment","volume":"110","author":"Lutz","year":"2013","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.bpg.2016.11.001_bib23","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1572-0241.2004.04067.x","article-title":"Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis","volume":"99","author":"Burak","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2016.11.001_bib24","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2016.11.001_bib25","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jhep.2008.08.013","article-title":"High lifetime risk of cancer in primary sclerosing cholangitis","volume":"50","author":"Claessen","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpg.2016.11.001_bib26","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12029-008-9040-0","article-title":"Cholangiocarcinoma: expanding the spectrum of risk factors","volume":"39","author":"Elfaki","year":"2008","journal-title":"J\u00a0Gastrointest Cancer"},{"key":"10.1016\/j.bpg.2016.11.001_bib27","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s11605-015-2918-9","article-title":"Surgical management of Caroli's disease: single center experience and review of the literature","volume":"19","author":"Moslim","year":"2015","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"Suppl. 4","key":"10.1016\/j.bpg.2016.11.001_bib28","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/annonc\/10.suppl_4.S308","article-title":"Risk factors for biliary tract carcinogenesis","volume":"10","author":"Chapman","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bpg.2016.11.001_bib29","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00268-014-2831-5","article-title":"What is the incidence of biliary carcinoma in choledochal cysts, when do they develop, and how should it affect management?","volume":"39","author":"Sastry","year":"2015","journal-title":"World J Surg"},{"key":"10.1016\/j.bpg.2016.11.001_bib30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.soc.2008.12.001","article-title":"Molecular mechanisms of cholangiocarcinogenesis: are biliary intraepithelial neoplasia and intraductal papillary neoplasms of the bile duct precursors to cholangiocarcinoma?","volume":"18","author":"Bickenbach","year":"2009","journal-title":"Surg Oncol Clin N Am"},{"issue":"Suppl. 3","key":"10.1016\/j.bpg.2016.11.001_bib31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/jso.2930530535","article-title":"Precancerous lesions of the biliary tree","volume":"53","author":"Callea","year":"1993","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.bpg.2016.11.001_bib32","doi-asserted-by":"crossref","first-page":"805973","DOI":"10.1155\/2014\/805973","article-title":"What are the precursor and early lesions of peripheral intrahepatic cholangiocarcinoma?","volume":"2014","author":"Nakanuma","year":"2014","journal-title":"Int J Hepatol"},{"key":"10.1016\/j.bpg.2016.11.001_bib33","first-page":"1187","article-title":"Increased risk of death in thorotrast-exposed patients during the late follow-up period","volume":"78","author":"Kato","year":"1987","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.bpg.2016.11.001_bib34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/jvh.12093","article-title":"The role of the hepatitis viruses in cholangiocarcinoma","volume":"20","author":"Ralphs","year":"2013","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.bpg.2016.11.001_bib35","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/hep.510280404","article-title":"Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark","volume":"28","author":"Sorensen","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2016.11.001_bib36","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1053\/j.gastro.2004.12.048","article-title":"Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study","volume":"128","author":"Shaib","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2016.11.001_bib37","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.canep.2015.04.002","article-title":"Diabetes mellitus: possible risk and promoting factors of cholangiocarcinoma: association of diabetes mellitus and cholangiocarcinoma","volume":"39","author":"Saengboonmee","year":"2015","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.bpg.2016.11.001_bib38","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3748\/wjg.v19.i4.457","article-title":"Obesity and cholangiocarcinoma","volume":"19","author":"Parsi","year":"2013","journal-title":"World J Gastroenterol WJG"},{"key":"10.1016\/j.bpg.2016.11.001_bib39","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/liv.12618","article-title":"Risk factors for perihilar cholangiocarcinoma: a hospital-based case-control study","volume":"35","author":"Lee","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.bpg.2016.11.001_bib40","article-title":"Risk factors for cholangiocarcinoma: aspirin-use and the risk of cholangiocarcinoma","author":"Choi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2016.11.001_bib41","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bpg.2015.02.004","article-title":"Radiological diagnosis in cholangiocarcinoma: application of computed tomography, magnetic resonance imaging, and positron emission tomography","volume":"29","author":"Ringe","year":"2015","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2016.11.001_bib42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1245\/s10434-008-0180-z","article-title":"A\u00a0proposed staging system for intrahepatic cholangiocarcinoma","volume":"16","author":"Nathan","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.bpg.2016.11.001_bib43","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1470-7330-14-14","article-title":"Imaging of malignancies of the biliary tract- an update","volume":"14","author":"Hennedige","year":"2014","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.bpg.2016.11.001_bib44","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11547-008-0225-1","article-title":"Intrahepatic peripheral cholangiocarcinoma (IPCC): comparison between perfusion ultrasound and CT imaging","volume":"113","author":"D'Onofrio","year":"2008","journal-title":"Radiol Med"},{"key":"10.1016\/j.bpg.2016.11.001_bib45","doi-asserted-by":"crossref","first-page":"349172","DOI":"10.1155\/2015\/349172","article-title":"Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: controversy over the ASSLD guideline","volume":"2015","author":"Guo","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.bpg.2016.11.001_bib46","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2214\/ajr.168.4.9124155","article-title":"Cholangiocarcinoma at the hepatic hilus: sonographic findings","volume":"168","author":"Hann","year":"1997","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.bpg.2016.11.001_bib47","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/jcu.1870230305","article-title":"Staging of hilar cholangiocarcinoma with ultrasound","volume":"23","author":"Neumaier","year":"1995","journal-title":"J\u00a0Clin Ultrasound"},{"key":"10.1016\/j.bpg.2016.11.001_bib48","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2214\/ajr.180.3.1800687","article-title":"Hilar biliary obstruction: preliminary results with Levovist-enhanced sonography","volume":"180","author":"Khalili","year":"2003","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.bpg.2016.11.001_bib49","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1186\/s12885-015-1475-7","article-title":"Cohort profile: cholangiocarcinoma screening and care program (CASCAP)","volume":"15","author":"Khuntikeo","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bpg.2016.11.001_bib50","first-page":"782","article-title":"Utility of intraductal ultrasonography as a diagnostic tool in patients with early distal cholangiocarcinoma","volume":"62","author":"Ito","year":"2015","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.bpg.2016.11.001_bib51","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nrgastro.2015.182","article-title":"Evaluation of indeterminate biliary strictures","volume":"13","author":"Bowlus","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2016.11.001_bib52","doi-asserted-by":"crossref","first-page":"582","DOI":"10.4253\/wjge.v7.i6.582","article-title":"Cholangiocarcinoma and malignant bile duct obstruction: a review of last decades advances in therapeutic endoscopy","volume":"7","author":"Bertani","year":"2015","journal-title":"World J Gastrointest Endosc"},{"key":"10.1016\/j.bpg.2016.11.001_bib53","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4251\/wjgo.v6.i11.420","article-title":"Usefulness of endoscopic ultrasound-guided fine needle aspiration in the diagnosis of hepatic, gallbladder and biliary tract Lesions","volume":"6","author":"Hammoud","year":"2014","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.bpg.2016.11.001_bib54","first-page":"1862","article-title":"Role of EUS\/EUS-guided FNA in the management of proximal biliary strictures","volume":"58","author":"Nayar","year":"2011","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.bpg.2016.11.001_bib55","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.gie.2007.07.018","article-title":"EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma","volume":"67","author":"Gleeson","year":"2008","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bpg.2016.11.001_bib56","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1572-0241.2003.04006.x","article-title":"EUS-guided fine-needle aspiration of suspected hilar cholangiocarcinoma in potentially operable patients with negative brush cytology","volume":"99","author":"Fritscher-Ravens","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2016.11.001_bib57","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/MCG.0b013e3182745d9f","article-title":"Patients with obstructive jaundice and biliary stricture +\/- mass lesion on imaging: prevalence of malignancy and potential role of EUS-FNA","volume":"47","author":"Tummala","year":"2013","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2016.11.001_bib58","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.cgh.2007.02.027","article-title":"Endoscopic ultrasound: a meta-analysis of test performance in suspected biliary obstruction","volume":"5","author":"Garrow","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2016.11.001_bib59","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.gie.2010.08.050","article-title":"Role of EUS for preoperative evaluation of cholangiocarcinoma: a large single-center experience","volume":"73","author":"Mohamadnejad","year":"2011","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bpg.2016.11.001_bib60","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.gie.2013.12.031","article-title":"EUS-FNA is superior to ERCP-based tissue sampling in suspected malignant biliary obstruction: results of a prospective, single-blind, comparative study","volume":"80","author":"Weilert","year":"2014","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bpg.2016.11.001_bib61","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4329\/wjr.v7.i2.28","article-title":"Imaging and interventions in hilar cholangiocarcinoma: a review","volume":"7","author":"Madhusudhan","year":"2015","journal-title":"World J Radiol"},{"key":"10.1016\/j.bpg.2016.11.001_bib62","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1002\/hep.24679","article-title":"Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis","volume":"54","author":"Fowler","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2016.11.001_bib63","first-page":"721","article-title":"Magnetic resonance cholangiography: past, present and future: a review","volume":"14","author":"Maccioni","year":"2010","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.bpg.2016.11.001_bib64","first-page":"497942","article-title":"Radiological imaging for assessing the respectability of hilar cholangiocarcinoma: a systematic review and meta-analysis","volume":"2015","author":"Zhang","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.bpg.2016.11.001_bib65","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2214\/ajr.183.5.1831327","article-title":"MDCT cholangiography with volume rendering for the assessment of patients with biliary obstruction","volume":"183","author":"Ahmetoglu","year":"2004","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.bpg.2016.11.001_bib66","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s002610000081","article-title":"Preoperative evaluation of Klatskin tumor: accuracy of spiral CT in determining vascular invasion as a sign of unresectability","volume":"25","author":"Cha","year":"2000","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.bpg.2016.11.001_bib67","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1148\/radiology.204.2.9240550","article-title":"Peripheral cholangiocarcinoma of the liver: two-phase spiral CT findings","volume":"204","author":"Kim","year":"1997","journal-title":"Radiology"},{"key":"10.1016\/j.bpg.2016.11.001_bib68","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s11604-008-0249-4","article-title":"Preoperative assessment of hilar cholangiocarcinoma using multidetector-row CT: correlation with histopathological findings","volume":"26","author":"Watadani","year":"2008","journal-title":"Radiat Med"},{"key":"10.1016\/j.bpg.2016.11.001_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1620\/tjem.217.1","article-title":"Correct diagnosis of vascular encasement and longitudinal extension of hilar cholangiocarcinoma by four-channel multidetector-row computed tomography","volume":"217","author":"Okumoto","year":"2009","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.bpg.2016.11.001_bib70","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2214\/AJR.07.2310","article-title":"Preoperative evaluation of bile duct cancer: MRI combined with MR cholangiopancreatography versus MDCT with direct cholangiography","volume":"190","author":"Park","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.bpg.2016.11.001_bib71","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2214\/ajr.171.3.9725291","article-title":"Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma","volume":"171","author":"Tillich","year":"1998","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.bpg.2016.11.001_bib72","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1148\/radiol.2383050419","article-title":"Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria","volume":"239","author":"Lee","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.bpg.2016.11.001_bib73","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.amjsurg.2006.10.024","article-title":"High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma","volume":"193","author":"Aloia","year":"2007","journal-title":"Am J Surg"},{"key":"10.1016\/j.bpg.2016.11.001_bib74","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.ejso.2005.05.012","article-title":"Significance of fluorodeoxyglucose PET imaging in the diagnosis of malignancies in patients with biliary stricture","volume":"31","author":"Wakabayashi","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.bpg.2016.11.001_bib75","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.gassur.2003.10.003","article-title":"Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma","volume":"8","author":"Anderson","year":"2004","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.bpg.2016.11.001_bib76","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1053\/jhep.2001.23912","article-title":"Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer","volume":"33","author":"Kluge","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2016.11.001_bib77","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jhep.2006.03.009","article-title":"Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma","volume":"45","author":"Petrowsky","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpg.2016.11.001_bib78","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/00006231-200112000-00002","article-title":"FDG PET in the diagnosis of hilar cholangiocarcinoma","volume":"22","author":"Fritscher-Ravens","year":"2001","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.bpg.2016.11.001_bib79","first-page":"127","article-title":"Peroral cholangioscopy facilitates targeted tissue acquisition in patients with suspected cholangiocarcinoma","volume":"60","author":"Liu","year":"2014","journal-title":"Minerva Gastroenterol Dietol"},{"key":"10.1016\/j.bpg.2016.11.001_bib80","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1055\/s-2006-925257","article-title":"Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis","volume":"38","author":"Tischendorf","year":"2006","journal-title":"Endoscopy"},{"key":"10.1016\/j.bpg.2016.11.001_bib81","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bpg.2015.02.005","article-title":"Endoscopic diagnosis of cholangiocarcinoma: from endoscopic retrograde cholangiography to bile proteomics","volume":"29","author":"Voigtlander","year":"2015","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2016.11.001_bib82","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.gie.2014.09.017","article-title":"Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures: a systematic review and meta-analysis","volume":"81","author":"Navaneethan","year":"2015","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bpg.2016.11.001_bib83","first-page":"268","article-title":"Predictors for detection of cancer in patients with indeterminate biliary stricture and atypical cells on endoscopic retrograde brush cytology","volume":"15","author":"Navaneethan","year":"2014","journal-title":"J\u00a0Dig Dis"},{"key":"10.1016\/j.bpg.2016.11.001_bib84","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3748\/wjg.14.1097","article-title":"Endoscopic transpapillary brush cytology and forceps biopsy in patients with hilar cholangiocarcinoma","volume":"14","author":"Weber","year":"2008","journal-title":"World J Gastroenterol WJG"},{"key":"10.1016\/j.bpg.2016.11.001_bib85","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.08.046","article-title":"An optimized set of fluorescence in situ hybridization probes for detection of pancreatobiliary tract cancer in cytology brush samples","volume":"149","author":"Barr Fritcher","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2016.11.001_bib86","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/cyt.12170","article-title":"FISHing for pancreatobiliary tract malignancy in endoscopic brushings enhances the sensitivity of routine cytology","volume":"25","author":"Barr Fritcher","year":"2014","journal-title":"Cytopathology"},{"key":"10.1016\/j.bpg.2016.11.001_bib87","doi-asserted-by":"crossref","first-page":"669","DOI":"10.5009\/gnl13292","article-title":"Triple-tissue sampling during endoscopic retrograde cholangiopancreatography increases the overall diagnostic sensitivity for cholangiocarcinoma","volume":"8","author":"Lee","year":"2014","journal-title":"Gut Liver"},{"key":"10.1016\/j.bpg.2016.11.001_bib88","doi-asserted-by":"crossref","first-page":"10495","DOI":"10.3748\/wjg.v20.i30.10495","article-title":"Comparative analysis of ERCP, IDUS, EUS and CT in predicting malignant bile duct strictures","volume":"20","author":"Heinzow","year":"2014","journal-title":"World J Gastroenterol WJG"},{"key":"10.1016\/j.bpg.2016.11.001_bib89","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/MOG.0b013e32835005bc","article-title":"Endoscopic ultrasound staging of cholangiocarcinoma","volume":"28","author":"Levy","year":"2012","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.bpg.2016.11.001_bib90","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.gie.2011.12.005","article-title":"Intraductal aspiration: a promising new tissue-sampling technique for the diagnosis of suspected malignant biliary strictures","volume":"75","author":"Curcio","year":"2012","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bpg.2016.11.001_bib91","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s11901-015-0261-y","article-title":"Screening for hepatocellular carcinoma and cholangiocarcinoma: can biomarkers replace imaging?","volume":"14","author":"Lozada","year":"2015","journal-title":"Curr Hepatol Rep"},{"key":"10.1016\/j.bpg.2016.11.001_bib92","doi-asserted-by":"crossref","first-page":"105358","DOI":"10.1155\/2015\/105358","article-title":"Novel serum biomarkers to differentiate cholangiocarcinoma from benign biliary tract diseases using a proteomic approach","volume":"2015","author":"Janvilisri","year":"2015","journal-title":"Dis Markers"},{"key":"10.1016\/j.bpg.2016.11.001_bib93","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1007\/s11605-013-2182-9","article-title":"A\u00a0prospective proteomic-based study for identifying potential biomarkers for the diagnosis of cholangiocarcinoma","volume":"17","author":"Shi","year":"2013","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.bpg.2016.11.001_bib94","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.12659\/MSM.895040","article-title":"Diagnostic accuracy of serum CA19-9 in patients with cholangiocarcinoma: a systematic review and meta-analysis","volume":"21","author":"Liang","year":"2015","journal-title":"Med Sci Monit"},{"issue":"Suppl. 17\u201327","key":"10.1016\/j.bpg.2016.11.001_bib95","article-title":"State of serum markers for detection of cholangiocarcinoma","volume":"13","author":"Wongkham","year":"2012","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"10.1016\/j.bpg.2016.11.001_bib96","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.22441","article-title":"Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis","volume":"48","author":"Charatcharoenwitthaya","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2016.11.001_bib97","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1309\/J030JYPWKQTHCLNJ","article-title":"Biliary brush cytology and the detection of cholangiocarcinoma in primary sclerosing cholangitis: evaluation of specific cytomorphologic features and CA19-9 levels","volume":"124","author":"Furmanczyk","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.bpg.2016.11.001_bib98","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/cncy.21331","article-title":"Primary sclerosing cholangitis with equivocal cytology: fluorescence in situ hybridization and serum CA 19-9 predict risk of malignancy","volume":"121","author":"Barr Fritcher","year":"2013","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.bpg.2016.11.001_bib99","first-page":"6663","article-title":"Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a preliminary case-control study","volume":"34","author":"Lumachi","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.bpg.2016.11.001_bib100","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.7314\/APJCP.2015.16.8.3451","article-title":"Application of joint detection of AFP, CA19-9, CA125 and CEA in identification and diagnosis of cholangiocarcinoma","volume":"16","author":"Li","year":"2015","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"10.1016\/j.bpg.2016.11.001_bib101","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1055\/s-2004-828891","article-title":"Serum and bile markers for cholangiocarcinoma","volume":"24","author":"Nehls","year":"2004","journal-title":"Seminars Liver Dis"},{"key":"10.1016\/j.bpg.2016.11.001_bib102","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s10620-014-3472-0","article-title":"Serum CYFRA 21-1 in biliary tract cancers: a reliable biomarker for gallbladder carcinoma and intrahepatic cholangiocarcinoma","volume":"60","author":"Huang","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bpg.2016.11.001_bib103","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ajpath.2011.09.010","article-title":"Heat shock proteins 27 and 70 are potential biliary markers for the detection of cholangiocarcinoma","volume":"180","author":"Sato","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bpg.2016.11.001_bib104","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.7314\/APJCP.2015.16.9.3697","article-title":"High expression of matrix metalloproteinase-11 indicates poor prognosis in human cholangiocarcinoma","volume":"16","author":"Tongtawee","year":"2015","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"10.1016\/j.bpg.2016.11.001_bib105","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2007.05.017","article-title":"Enhanced detection of cholangiocarcinoma with serum trypsinogen-2 in patients with severe bile duct strictures","volume":"47","author":"Lempinen","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpg.2016.11.001_bib106","doi-asserted-by":"crossref","first-page":"4670","DOI":"10.1021\/pr800215n","article-title":"Differential membrane proteomics using 18O-labeling to identify biomarkers for cholangiocarcinoma","volume":"7","author":"Kristiansen","year":"2008","journal-title":"J\u00a0Proteome Res"},{"key":"10.1016\/j.bpg.2016.11.001_bib107","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/gastro\/gou066","article-title":"Bile proteomics for differentiation of malignant from benign biliary strictures: a pilot study","volume":"3","author":"Navaneethan","year":"2015","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"10.1016\/j.bpg.2016.11.001_bib108","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/hep.24103","article-title":"Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis","volume":"53","author":"Lankisch","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2016.11.001_bib109","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/gutjnl-2012-302047","article-title":"Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders","volume":"62","author":"Metzger","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2016.11.001_bib110","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.cca.2016.05.007","article-title":"Screening for circulating RAS\/RAF mutations by multiplex digital PCR","volume":"458","author":"Andersen","year":"2016","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.bpg.2016.11.001_bib111","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12885-015-1270-5","article-title":"A\u00a0microRNA profile associated with Opisthorchis viverrini-induced cholangiocarcinoma in tissue and plasma","volume":"15","author":"Plieskatt","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bpg.2016.11.001_bib112","doi-asserted-by":"crossref","first-page":"18631","DOI":"10.18632\/oncotarget.4072","article-title":"Serum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinoma","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bpg.2016.11.001_bib113","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/lt.23872","article-title":"MicroRNAs in the bile of patients with biliary strictures after liver transplantation","volume":"20","author":"Lankisch","year":"2014","journal-title":"Liver Transplant"},{"key":"10.1016\/j.bpg.2016.11.001_bib114","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/hep.27707","article-title":"Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma","volume":"61","author":"Andresen","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2016.11.001_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.gie.2014.09.041","article-title":"Volatile organic compounds in bile for early diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis: a pilot study","volume":"81","author":"Navaneethan","year":"2015","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bpg.2016.11.001_bib116","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/prca.201500019","article-title":"Upregulation of 14-3-3 eta in chronic liver fluke infection is a potential diagnostic marker of cholangiocarcinoma","volume":"10","author":"Haonon","year":"2016","journal-title":"Proteom Clin Appl"},{"key":"10.1016\/j.bpg.2016.11.001_bib117","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.compbiolchem.2013.08.010","article-title":"Gene expression patterns combined with bioinformatics analysis identify genes associated with cholangiocarcinoma","volume":"47","author":"Li","year":"2013","journal-title":"Comput Biol Chem"},{"key":"10.1016\/j.bpg.2016.11.001_bib118","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/cgt.2015.66","article-title":"Screening of potential biomarkers for cholangiocarcinoma by integrated analysis of microarray data sets","volume":"23","author":"Huang","year":"2016","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.bpg.2016.11.001_bib119","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1055\/s-2006-933562","article-title":"Primary sclerosing cholangitis and cholangiocarcinoma","volume":"26","author":"Lazaridis","year":"2006","journal-title":"Seminars Liver Dis"},{"key":"10.1016\/j.bpg.2016.11.001_bib120","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL clinical practice guidelines: management of cholestatic liver diseases","volume":"51","author":"European Association for the Study of the L","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpg.2016.11.001_bib121","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis","volume":"38","author":"Broome","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2016.11.001_bib122","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/hep.21964","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms","volume":"47","author":"Melum","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2016.11.001_bib123","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/hep.510270201","article-title":"Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study","volume":"27","author":"Bergquist","year":"1998","journal-title":"Hepatology"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169181630097X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169181630097X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T15:50:34Z","timestamp":1718898634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152169181630097X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":123,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S152169181630097X"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2016.11.001","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surveillance in cholangiocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpg.2016.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}